Background-Myocardial
xercise-induced cardiac remodeling is the process of structural and functional myocardial adaptation that occurs in response to exercise training. Cross-sectional studies of competitive athletes have documented a high prevalence of cardiac chamber enlargement [1] [2] [3] [4] and increased wall thickness 5, 6 and more recently, longitudinal studies have begun to clarify the causal relationship between exercise training and myocardial adaptation. [7] [8] [9] Recreational athletes, a growing population that is commonly encountered in clinical practice, perform far less exercise volume and do so at lower training intensities than elite athletes. To what degree the moderate intensity exercise training typically practiced by recreational athletes stimulates exercise-induced cardiac remodeling remains largely unknown.
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The popularity of marathon (42-km foot race) running has risen steadily over the past decade, in large part, because of increasing popularity among middle-aged runners seeking the reported health benefits of regular physical exercise. 10, 11 Most recreational marathoners train with a goal of safely completing the race distance and thus typically engage in several months of daily aerobic exercise that meet or exceed current public health recommendations. 12 Several recent studies have characterized the myocardial and biochemical responses to a single marathon run. [13] [14] [15] To date, the effects of the preparatory marathon training on cardiac structure and function have received comparatively little attention.
We hypothesized that recreational runners participating in a structured marathon training program would demonstrate evidence of exercise-induced cardiac remodeling similar to Myocardial Adaptations to Marathon Training that previously documented among more elite competitive athletes. To address this hypothesis, we performed a longitudinal, repeated measures study designed to examine the effect of recreational marathon training on cardiac structure, cardiac function, and relevant biological metrics, including cardiopulmonary fitness and cardiovascular disease risk factors.
Methods

Study Design Overview
We used a prospective, longitudinal, and repeated measures study design to examine the effects of marathon training on cardiac morphology and function among recreational athletes. Participants were assessed before and after an 18-week marathon-training program designed to facilitate completion of the 2013 Boston Athletic Association Boston Marathon. At baseline, a detailed demographic and clinical profile were collected via a written questionnaire that included assessment of previous long-term (baseline running mileage, number of previous marathons etc.) and recent (miles/wk, as well as total endurance hours/wk activity and strength training hours/wk) exercise exposure. Assessment at both time points included measurement of height, weight, resting vital signs, fasting blood sampling, echocardiographic evaluation, and cardiopulmonary exercise testing.
Patient Population
Individuals enrolled in the 2013 Boston Marathon Dana-Farber Marathon Challenge charity were recruited by email invitation. Charity runners were chosen for this study because they are more representative of typical middle-aged recreational marathon runners than the faster qualifying athletes that comprise the majority of the Boston Marathon field. Men ranging from 35 to 65 years were considered eligible for participation. Individuals were excluded if they had been previously diagnosed with any of the following conditions (1) coronary artery disease, (2) left ventricular (LV) dysfunction, (3) known genetic cardiomyopathy, or (4) valvular heart disease characterized by moderate or greater stenosis or regurgitation in any valve. To examine interactions between previous marathon running experience, baseline characteristics, and prespecified end points, we enrolled an equal number of more experienced marathon runners (defined as previous completion of >5 marathons) and less experienced runners (defined as previous completion of ≤5 marathons). The study was approved by the Partners Healthcare System Human Research Committee, and written informed consent was obtained from each patient at the time of enrollment.
Marathon Training Program
Participants were provided with a structured online training program that contained daily instructions detailing running mileage goals. Each week consisted of 3 to 4 basic training runs (4-8 miles [6.4-12. 9 km]) and 1 longer run that increased in distance throughout the 18-week calendar (maximal long-run distance, 20-22 miles [32.2-35.4 km], week 15). Optimal running effort (scale: 1 [easy] through 5 [maximal sustainable pace]) was specified for each run. Each participant was supervised throughout the study period by a single coach with >20 years of experience coaching marathoners. A training log was provided to each participant in which running volume (distance/wk, hours/wk) and injuries or adverse events were recorded. Individuals were excluded from the final analysis for training absences >2 weeks for any reason.
Cardiopulmonary Exercise Testing
Cardiopulmonary exercise testing was performed using a maximal effort-limited protocol with continuous electrocardiography and measurement of metabolic gas exchange. Participants abstained from all exercise for 24 hours before testing. A single exercise physiologist and study physician performed all testing. The cardiopulmonary exercise testing protocol consisted of a graded maximal effort test on a treadmill (Trackmaster TMX425C; Full Vision, Newton, KS). Specifically, after a 3-minute period of rest to facilitate ventilatory equilibration, participants ran at a 1% grade (to simulate air resistance) at a speed of 5 miles/h (8.0 km/h) for 10 minutes to facilitate musculoskeletal warm-up. After the 10-minute warm-up period, speed was maintained at a constant 5 mph (8.0 kph), whereas the incline increased by 0.5% every 15 s until exhaustion. Gas exchange data were measured breath-by-breath using a commercially available metabolic cart (Ultima CardiO2; Medgraphics, St. Paul, MN). Peak oxygen consumption (Vo 2 ) was defined as the highest O 2 uptake, averaged over a period of 30 s, during the last minute of symptom-limited exercise. 16 The ventilatory threshold was determined by the modified V-slope method. 17 Heart rate was continuously recorded during exercise using a wireless 12-lead ECG system (Mortara X12+ Transmitter; Mortara Instruments, Milwaukee, WI). Blood pressures were determined by auscultation using a manual sphygmomanometer before exercise, at 3-minute intervals during exercise, immediately after peak exercise, and at 3-minute intervals during recovery.
Echocardiography
Cardiac structure and function were assessed via transthoracic echocardiography (Vivid-I; GE Healthcare, Milwaukee, WI). A single experienced sonographer performed standard 2-dimensional (2D) and Doppler imaging at both study time points. A single experienced investigator who was blinded to study time point performed analysis of echocardiographic data. LV volumes, ejection fraction, and left atrial volumes were calculated using the modified biplane technique. 18 LV mass was calculated using the area-length method, and LV geometry was assessed using relative wall thickness. 18 Right ventricular (RV) end-diastolic area, end-systolic area, and fractional area change were measured from RV-optimized apical 4-chamber views. Myocardial tissue velocities were measured off-line from 2D color-coded tissue Doppler images and reported as the average of 3 consecutive cardiac cycles. Strain imaging was performed by speckled tracking analysis (EchoPac, version 6.5; GE Healthcare). The presence and severity of LV diastolic dysfunction were assessed in accordance with current recommendations. 19 Body surface area was calculated using the Mosteller formula. 20 Measurements are presented as raw data and after body surface area indexing when appropriate.
Application of Clinical Cut Points
Values defining the limits of normal cardiac structure and function were adopted from the American Society of Echocardiography/ European Association of Echocardiography chamber quantification and diastolic function recommendations. 18, 19 Normal cut point values applied for these analyses included LV end-diastolic volume index (≥76 mL/m 2 ), RV end-diastolic area (≥29.0 cm 
Biochemical Studies
Fasting (>12 hours) venous blood samples were collected at both study time points before exercise testing. Samples were taken 24 hours after the last bout of exercise. Blood was collected into standard anticoagulant Ethylenediaminetetraacetic acid-treated vacutainer tubes and into serum separator tubes and processed immediately. Testing for all of the assays was done in a random batch order, testing personnel were unaware of the clinical status of participants, and all testing was performed in a Clinical Laboratory Improvement Amendments certified laboratory. Laboratory parameters assessed included a complete chemistry profile, complete blood count, iron studies, endocrine profile (thyroid stimulating hormone, free serum testosterone, and steroid hormone binding globulin), lipid profile (total cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides), and additional biomarkers of cardiovascular risk (hemoglobin A1C, high-sensitivity C-reactive protein, lipoprotein-(a), and N-terminal fragment of B-type natriuretic peptide).
Statistical Analysis
Normality of distribution for all variables was assessed using the Shapiro-Wilk test. Continuous variables are reported as mean±SD and categorical variables as ratios. Baseline variables characterizing more experienced and less experienced runners were compared using 1-sample t tests or the Mann-Whitney test for continuous variables, as appropriate for data distribution, and Fisher Exact test for proportions. Before and after training variables in the total cohort were compared using paired t testing or the Wilcoxon matched pairs test as appropriate for data distribution. The percentages of participants that fell outside conventional limits of normal before and after training were compared using Fisher exact test. ANOVA and linear regression analyses were used to examine the relationships between exercise exposure (weekly running mileage at baseline, number of previous marathons completed, previous personal best marathon time, and number of miles run during the study period) and changes in key outcome variables. Data analysis was performed using the Statistical Package for the Social Sciences (SPSS) software (SPSS Inc, Chicago, IL). A 2-sided P value of <0.05 was considered significant.
Results
Baseline Characteristics
Forty-five of 49 enrolled participants (92% completion rate) completed the training period and were included in the final analyses. All subject attrition (n=4) was because of musculoskeletal injuries, and there were no adverse cardiovascular events during the study period. Baseline demographics, anthropometric data, vital signs, cardiac history, medication use, and exercise history are detailed in Table 1 . The mean age was 48±7 years, and the majority of participants were white (40/45; 89%). Established cardiovascular conditions included previous syncope (13/45; 29%), dyslipidemia (19/45; 42%), hypertension (13/45; 29%), LV diastolic dysfunction (7/45; 16%), and previous palpitations (6/45; 13%). No individuals started or discontinued any prescription medications during the study period. Compared with less experienced runners (n=23; 1.1±1.1 previous marathons), more experienced marathoners (n=22; 8.8±10.2 previous marathons) were older, shorter, lighter, and reported more weekly alcohol consumption but were otherwise similar at baseline. More experienced wk compared with prestudy baseline running) and demonstrated a progressive increase in weekly running distance until the 3 weeks before race day during which training volume decreased to facilitate a taper for optimal recovery and race day performance (Figure 1 ).
Exercise Physiology
Exercise physiology parameters before and after training are shown in 
Cardiac Structure
Cardiac structural indices are detailed in Table 3 . Before training, more experienced runners and less experienced marathon runners were similar across all structural parameters with the exception of LV length, which was higher in the more experienced group. Marathon training was associated with statistically significant increases in LV size as measured by end-diastolic volume, end-systolic volume, longitudinal length, and LV mass index (78.1±14.8 versus 89.3±9.7 g/m 2 ; P<0.001). Similarly, there were significant increases in RV size and left atrial volume. There were no statistically significant relationships between previous marathon running experience, intrastudy training volume, and changes in cardiac structure.
Cardiac Function
Parameters defining cardiac function before and after marathon training are detailed in Table 3 . Before training, more experienced runners and less experienced marathon runners were similar across all functional parameters. LV diastolic function, as assessed both by early diastolic relaxation velocity (E′=12.4±2.5 versus 13.2±20 cm/s; P=0.007) and late diastolic relaxation velocity (A′=11.5±1.9 versus 12.2±2.1 cm/s; P=0.03), was enhanced after marathon training. Complementary indices of LV and RV systolic function (ejection fraction, RV fractional area change, basal LV and RV S′, global LV longitudinal strain, and tricuspid annular plane systolic excursion) were not significantly affected by marathon training. There were no statistically significant relationships between previous marathon running experience, intrastudy training volume, and changes in cardiac function.
Application of Clinical Cut Points
The application of established clinical cut points for measurements of cardiac structure and function for selected metrics is shown in Figure 2 . At the completion of marathon training, indices defining cardiac structure, including LV end-diastolic 
Laboratory Markers
Biochemical, endocrine, and hematologic parameters before and after training are displayed in Table 4 . Most notably, marathon training was associated with significant improvements in serum lipid concentrations (Figure 3 23 To what degree these adaptations occur in recreational athletes who typically perform far less exercise than elite competitors remains uncertain. Our findings suggest that a recreational running program is sufficient to stimulate both the structural and the functional cardiac changes that have previously been documented among elite competitors. The observed structural remodeling in this setting was of sufficient magnitude such that post-training cardiac parameters commonly fell outside the established clinical ranges of normal. Thus, structural characteristics of the athlete's heart are not confined to elite caliber competitors and are likely to be found among a sizable population of active people. It is also noteworthy that among the 16% of participants with ≥ grade 1 LV diastolic dysfunction before training, LV diastolic function normalized in all but in 1 case after training. It is noteworthy that the majority of the individuals (6 /7) with pretraining diastolic dysfunction were experienced marathoners, which may reflect the age-associated decline in ventricular relaxation because the experienced marathoners were older than the less experienced marathoners. This beneficial adaptation suggests a key mechanistic link between A-wave indicates late mitral inflow filling velocity; basal A′, late diastolic peak tissue velocity; basal E′, early diastolic peak tissue velocity; basal S′, peak systolic tissue velocity; BSA, body surface area; E/A ratio, ratio of early to late ventricular filling velocities; E-wave, early mitral inflow filling velocity; LAEDV, left atrial end-diastolic volume; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; RV, right ventricular; RVAd, right ventricular area in diastole; RVFAC, right ventricular fractional area change; RVIDd, right ventricular internal dimension in diastole; and TAPSE, tricuspid annular plane systolic excursion. *P value <0.05 comparing pretraining values to posttraining values. Myocardial Adaptations to Marathon Training recreational exercise and reduced cardiovascular disease burden. Finally, we observed that a significant minority of recreational athletes, both before and after a period of structured training, demonstrated mildly reduced resting left and RV systolic function coupled with well-above normal exercise capacity. This observation suggests, as previously proposed, 24 that mild depressed resting systolic function in the endurance exercise trained heart may reflect increased contractile reserve rather than an acquired cardiomyopathic condition.
Recreational endurance sports, such as marathon running, have become a popular pastime for many middle-aged people. Growth in marathon popularity has been driven, in part, by the popular notion that marathon training may confer potential health benefits. 25 At present, there are sparse data substantiating this belief. There is, however, a rapidly growing body of literature documenting potentially concerning cardiovascular responses to marathon racing, including cardiac troponin release, 26 subclinical cardiac dysfunction, 14 and myocardial edema. 13 These findings have generated logical concern about the overall health implications of marathon participation. 27 However, observations on transient physiological changes associated with a single intense race, most without apparent clinical relevance, are unlikely to reflect the overall effect of marathon participation on cardiovascular health. Data from the present study, an effort aimed to evaluate the effect of the months of training rather than the hours of the race itself, suggest that the preparatory phase of marathon participation translates into tangible cardiovascular health benefits. To what degree the benefits of training are offset by the proposed dangers of racing and maintenance of these benefits during the offseason remain important questions that will require future work.
There are direct clinical implications of our findings because recreational athletes, specifically long-distance runners, are increasingly encountered in clinical practice. Data defining the expected physiological adaptations to recreational marathon training may serve to reduce unnecessary testing directed at the evaluation of suspected underlying cardiomyopathy in this population. This is particularly relevant given that ventricular dilation coupled with mild reduction in systolic function, a pattern typical of mild cardiomyopathic conditions, was common among the healthy group of athletes studied. In addition to facilitating the differentiation of adaptation from occult disease, clinicians are frequently asked to opine on the potential health risks and benefits of participating in vigorous physical activity. Data presented here may enable clinicians to provide quantitative expectations about the effect of recreational marathon training on modifiable cardiac disease risk factors better ( Figure 3 ). Our data demonstrate that recreational marathon training may facilitate reversal of LV diastolic dysfunction as was observed in the majority of our participants with this condition before training. This finding substantiates important previous work, which demonstrated that aerobic exercise can prevent or mitigate age-associated decline in LV relaxation. 28 The observed reductions in body mass, 29, 30 increases in peak aerobic capacity, 31, 32 and improvements in serum lipids should also translate into improved cardiovascular health. The observed 5% decrease in low-density lipoprotein cholesterol is similar to that afforded by the low saturated fat, low cholesterol American Heart Association Step 2 diet, 33 and by low potency statins. 34 Low-density lipoprotein reduction, even at this magnitude, has been associated with significant reductions in mortality. 35 It is noteworthy that previous cross-sectional work has examined the incidence of atherosclerosis among marathon runners. A case control study 36 Thus, although our data suggest that marathon training may decrease CV risk factors in the short term, longer term studies adequately powered to evaluate firm morbidity and mortality end points will be needed to delineate the downstream implications of these findings fully.
Participants in the present study were not exercise naïve and had a broad range of previous marathon running experience. It is somewhat surprising that we did not detect any significant differences in baseline characteristics between more experienced and less experienced marathon runners. This is best explained by the fact that both groups entered the study in the relatively detrained states and, therefore, suggests that cardiac adaptations associated with exercise training regress after periods of reduced activity. It is further noteworthy that we did not detect any statistically significant dose-response relationships between intrastudy training volume (ie, number of miles run per week) and key outcome variables. This is most likely because of the fact that the range of training among our participants was too small to examine this important concept effectively. We are, therefore, unable to comment on whether the adaptations we observed would amplify or diminish with exercise training that falls outside the range of that which we studied. Interestingly, the exercise dose that we studied of ≈25 running miles/wk is in-line with recent observational data, suggesting that moderate, not extreme, amounts of physical exercise promote optimal long-term health. 37 Further study focused on defining both the durability of myocardial adaptations and optimal dose-response relationships between exercise, cardiac remodeling, and cardiovascular disease risk reduction is warranted.
There are several limitations of this study. First, we deliberately chose to study middle-aged, recreational male runners, a population we previously identified as being at highest risk for adverse cardiovascular events during marathon running. 38 Our results, therefore, may not be fully applicable to recreational female runners, more elite caliber athletes, or to individuals with established cardiovascular disease. Second, we made no effort to control diet during this study and thus cannot comment on the potential effect of food intake on our observations. It is possible that marathon training coupled with a heart healthy diet would lead to more robust improvements than those observed. Finally, we planned to examine the relationships between final marathon finish time and key outcome variables. This was not however possible because of the bombings that occurred on April 15, 2013, which made finishing the race impossible for a significant portion of our participants.
In summary, this study demonstrates that recreational marathon training facilitates a specific pattern of exerciseinduced cardiac remodeling characterized by biventricular dilation, left atrial dilation, and enhanced LV diastolic function. These adaptive myocardial responses seem to be paralleled by numerous beneficial adaptations, including increased cardiorespiratory fitness, decreased body mass, and improved serum lipid profiles. Additional work is necessary to assess the durability of these beneficial adaptations and the cumulative effects longer term training. Yet, these findings suggest that recreational marathon training, a widely accessible and increasingly popular activity, may represent an effective platform for improving cardiovascular health.
